Q&A with David Loren: Integrated Molecular Pathology Impacts Real-Life Pancreatitis Management


It's a constant question of whether physician decision making has benefitted the patients or not.

David Loren, MD, Thomson Jefferson University discussed how this molecular diagnostic affected changes in management decisions for surgery versus watching patients with pancreatic lesions than current International Consensus Guideline recommendations.

Loren said that at the end of the day, while impacting physician decision making on these patients, the question is, "Have we really benefited the patients or not?

Related Videos
Chamil Codipilly, MD: Vonoprazan and PCABs for GERD
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
© 2023 MJH Life Sciences

All rights reserved.